Cargando…

Predictors of functional benefit of hepatitis C therapy in a ‘real-life’ cohort

AIM: To define predictors of functional benefit of direct-acting antivirals (DAAs) in patients with chronic hepatitis C virus (HCV) infection and liver cirrhosis. METHODS: We analysed a cohort of 199 patients with chronic HCV genotype 1, 2, 3 and 4 infection involving previously treated and untreate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steinebrunner, Niels, Stein, Kerstin, Sandig, Catharina, Bruckner, Thomas, Stremmel, Wolfgang, Pathil, Anita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807943/ https://www.ncbi.nlm.nih.gov/pubmed/29467555 http://dx.doi.org/10.3748/wjg.v24.i7.852

Ejemplares similares

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort
por: Steinebrunner, Niels, et al.
Publicado: (2015)

Pharmacologic cholinesterase inhibition improves survival in acetaminophen-induced acute liver failure in the mouse
por: Steinebrunner, Niels, et al.
Publicado: (2014)

Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy
por: Chautant, Fiona, et al.
Publicado: (2020)

Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease
por: Hoffmann, Peter, et al.
Publicado: (2019)

Acute liver failure and death predictors in patients with dengue-induced severe hepatitis
por: Teerasarntipan, Tongluk, et al.
Publicado: (2020)

Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
por: Lovett, Grace C, et al.
Publicado: (2017)

Soluble mannose receptor as a predictor of prognosis of hepatitis B virus-related acute-on-chronic liver failure
por: Li, Tai-Ping, et al.
Publicado: (2019)

Real-life multi-center retrospective analysis on nivolumab in difficult-to-treat patients with advanced hepatocellular carcinoma
por: De Wilde, Nika, et al.
Publicado: (2022)

Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study
por: Stasi, Cristina, et al.
Publicado: (2018)

Eight-week ledipasvir/sofosbuvir in non-cirrhotic, treatment-naïve hepatitis C genotype-1 patients with hepatitis C virus-RNA < 6 million: Single center, real world effectiveness and safety
por: Latt, Nyan L, et al.
Publicado: (2017)

Hepatic flow is an intraoperative predictor of early allograft dysfunction in whole-graft deceased donor liver transplantation: An observational cohort study
por: Lominchar, Pablo Lozano, et al.
Publicado: (2019)

Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
por: Chen, Ming-Yu, et al.
Publicado: (2020)

Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
por: Jung, Jang Han, et al.
Publicado: (2017)

Anti-inflammatory properties of ursodeoxycholyl lysophosphatidylethanolamide in endotoxin-mediated inflammatory liver injury
por: Ludwig, Johannes Maximilian, et al.
Publicado: (2018)

Effectiveness of a novel, fixed dose combination of netupitant and palonosetron in prevention of chemotherapy induced nausea and vomiting: A real-life study from India
por: Vaswani, Bharat, et al.
Publicado: (2020)

Psychological predictors of bipolarity in panic disorder
por: Oh, Da Hye, et al.
Publicado: (2021)

Efficacy and safety of endoscopic papillary balloon dilation for the removal of bile duct stones: Data from a “real-life” multicenter study on Dilation-Assisted Stone Extraction
por: Di Mitri, Roberto, et al.
Publicado: (2016)

Survival benefits and disparities in radiation therapy for elderly patients with pancreatic ductal adenocarcinoma
por: Cao, Bi-Yang, et al.
Publicado: (2023)

Hepatoprotectant Ursodeoxycholyl Lysophosphatidylethanolamide Increasing Phosphatidylcholine Levels as a Potential Therapy of Acute Liver Injury
por: Chamulitrat, Walee, et al.
Publicado: (2012)

Circulating Phospholipid Patterns in NAFLD Patients Associated with a Combination of Metabolic Risk Factors
por: Tiwari-Heckler, Shilpa, et al.
Publicado: (2018)

Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B
por: Hu, Yan-Chao, et al.
Publicado: (2017)

Predictors of distant metastasis in acinic cell carcinoma of the parotid gland
por: Ali, Syed Ahmed, et al.
Publicado: (2020)

Evaluating the benefit of adjuvant chemotherapy in patients with ypT0–1 rectal cancer treated with preoperative chemoradiotherapy
por: Jeon, Ye Won, et al.
Publicado: (2021)

On-treatment quantitative hepatitis B e antigen predicted response to nucleos(t)ide analogues in chronic hepatitis B
por: Gao, Yu-Hua, et al.
Publicado: (2016)

Expected outcomes and patients’ selection before chemoembolization—“Six-and-Twelve or Pre-TACE-Predict” scores may help clinicians: Real-life French cohorts results
por: Adhoute, Xavier, et al.
Publicado: (2021)

Pre- and intraoperative predictors of acute kidney injury after liver transplantation
por: Mrzljak, Anna, et al.
Publicado: (2020)

Oncological outcomes and predictors of radiofrequency ablation of colorectal cancer liver metastases
por: Wang, Chuan-Zhuo, et al.
Publicado: (2020)

Predictors of rebleeding and in-hospital mortality in patients with nonvariceal upper digestive bleeding
por: Lazăr, Daniela Cornelia, et al.
Publicado: (2019)

Gastrointestinal hemorrhage in the setting of gastrointestinal cancer: Anatomical prevalence, predictors, and interventions
por: Minhem, Mohamad A, et al.
Publicado: (2021)

Predictors for success of non-operative management of adhesive small bowel obstruction
por: Ng, Zi Qin, et al.
Publicado: (2023)

Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B
por: Abayli, Bahri, et al.
Publicado: (2021)

Real-world treatment attrition rates in advanced esophagogastric cancer
por: Tsang, Erica S, et al.
Publicado: (2020)

Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients
por: He, Xiaoping, et al.
Publicado: (2017)

Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations
por: Huang, Bi-Xia, et al.
Publicado: (2020)

Bivalent Ligand UDCA-LPE Inhibits Pro-Fibrogenic Integrin Signalling by Inducing Lipid Raft-Mediated Internalization
por: Su, Jie, et al.
Publicado: (2018)

Low platelet count: Predictor of death and graft loss after liver transplantation
por: Beltrame, Pedro, et al.
Publicado: (2019)

Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer
por: Chu, Yu-Ning, et al.
Publicado: (2019)

Chemotherapy predictors and a time-dependent chemotherapy effect in metastatic esophageal cancer
por: Midthun, Lauren, et al.
Publicado: (2022)

Predictors for malignant potential and deep submucosal invasion in colorectal laterally spreading tumors
por: Hao, Xiao-Wen, et al.
Publicado: (2022)

Clinical utility of hepatitis B surface antigen kinetics in treatment-naïve chronic hepatitis B patients during long-term entecavir therapy
por: Lin, Tien-Ching, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_njvamjvjtp34kf435cfqm6ohm3